Company Name:  ARIAD Pharmaceuticals Inc  Ticker Symbol:  ARIA  CIK Number:  0000884731  WWW Address:  http://www.ariad.com 
CEO:  Mr. Paris Panayiotopoulos  No. of Employees:  379 
Common Issue Type:  CS  Business Description:  Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

  Industry Information:  DRUGS  Biotechnology [more like this] 

Price  Day Change  Bid  Ask  Open  High  Low  Volume  23.99  0.0  23.8  22.88   23.97  23.97   
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
4,658.9  194.2  0.00  1.23  0.00  0.0  0.0  23.98  23.63 

KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  23.97  $  PE Ratio  LTM  0.0  
Market Capitalisation  4,658.9  mil 
Latest Shares Outstanding  194.2  mil 
Earnings pS (EPS)  1.23  $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee  258,832  $ 
Effective Tax Rate  0.0  % 
Float  157.8  mil 
Float as % of Shares Outstanding  0.8  % 
Foreign Sales  40  mil 
Domestic Sales  78  mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  1.40  % 
Research & Devlopment (R&D) as % of Revenue  1.40  % 
Gross Profit Margin  0.0  % 
EBITDA Margin  0.0  % 
PreTax Profit Margin  197.4  % 
Assets Turnover  0.0  % 
Return on Assets (ROA)  0.0  % 
Return on Equity (ROE)  0.0  % 
Return on Capital Invested (ROCI)  0.0  % 
Current Ratio   
Leverage Ratio (Assets/Equity)   
Interest Cover   
Total Debt/Equity (Gearing Ratio)   
LT Debt/Total Capital  0.0  % 
Working Capital pS  0.74  $ 
Cash pS  0.00  $ 
BookValue pS  0.24  $ 
Tangible BookValue pS  0.54  $ 
Cash Flow pS  0.83  $ 
Free Cash Flow pS  1.10  $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  100.00  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow  28.8  
Price/Free Cash Flow  21.7  
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  0.0 
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
  

PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        0.0  1  4,594,052  
4 Weeks  0.00  0.00  0.00  0.0  4   
13 Weeks  0.00  0.00  0.00  0.0  9   
26 Weeks  0.00  0.00  0.00  0.0  13   
52 Weeks  23.98  23.63  23.67  1.4  22  8,310,752  191,147,318 
YTD  0.00  0.00    0.0  3   
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 23.94  23.88  0.00  0.00  23.79  0.00  0.00 


GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue   0.0  
Income   0.0  
Dividend   0.0  
Capital Spending   NA  
R&D  25.20  NA  33.45 
Normalized Inc.  0.00  NA  0.00 
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %  7880.2  7880.2  97.8 
Earnings %  0.0  0.0  0.0 
EPS %  0.0  0.0  0.0 
EPS $  0.01  0.01  0.41 


SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  26.14 
Current Ratio  2.1 
Quick Ratio (Acid Test)  2.0 
Liquidity Ratio (Cash)  3.58 
Receivables Turnover  9.9 
Average Collection Period  36 
Working Capital/Equity  0.0 
Working Capital pS  0.75 
CashFlow pS  0.84 
Free CashFlow pS  0.94 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  2.89 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  81.0 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  152.2 
LT Debt/Total Liabilities  96.9 
Interest Cover  11.9 
Interest/Capital Invested  4.38 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  8.47 
Current P/E Ratio  LTM  0.00 
Enterprise Value (EV)/EBITDA  23.61 
Enterprise Value (EV)/Free Cash Flow  24.24 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  100.00 
Price/Cash Flow Ratio  28.8 
Price/Free Cash Flow Ratio  LTM  21.7 
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  0.0 
P/E Ratio (26 weeks ago)  LTM  0.0 
P/E Ratio (52 weeks ago)  LTM  0.0 
5Y High P/E Ratio  141.1 
5Y Low P/E Ratio  11.9 
5Y Average P/E Ratio  0.0 
Current P/E Ratio as % of 5Y Average P/E  
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  2.53 
Current Liabilities pS  0.78 
Tangible Book Value pS  LTM  0.54 
Book Value pS  LTM  0.24 
Capital Invested pS  1.75 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  0.83 
Free Cash Flow pS  LTM  1.10 
Earnings pS (EPS)  1.23 
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  148.52 
Free Cash Flow Margin 5YEAR AVG  5,875.67 
Net Profit Margin  1.9 
Net Profit Margin  5YEAR AVRG.  
Equity Productivity  1.15 
Return on Equity (ROE)  0.0 
Return on Equity (ROE)  5YEAR AVRG.  
Capital Invested Productivity  0.35 
Return on Capital Invested (ROCI)  0.0 
Return on Capital Invested (ROCI)  5YEAR AVRG.  
Assets Productivity  0.20 
Return on Assets (ROA)  0.4 
Return on Assets (ROA)  5YEAR AVRG.  
Gross Profit Margin  0.0 
Gross Profit Margin  5YEAR AVRG.  
EBITDA Margin  LTM  0.0 
EBIT Margin  LTM  0.0 
PreTax Profit Margin  0.0 
PreTax Profit Margin  5YEAR AVRG.  
Effective Tax Rate  0.1 
Effective Tax Rate  5YEAR AVRG.  0.0 
EFFICIENCY RATIOS 
Cash Conversion Cycle  424,004 
Revenue per Employee  258,832 
Net Income per Employee  
Average Collection Period  424,004 
Receivables Turnover  9.9 
Day's Inventory Turnover Ratio  
Inventory Turnover  2.0 
Inventory/Sales  0.9 
Accounts Payble/Sales  14.32 
Assets/Revenue  5.00 
Net Working Capital Turnover  0.83 
Fixed Assets Turnover  0.44 
Total Assets Turnover  0.2 
Revenue per $ Cash  0.51 
Revenue per $ Plant  0.47 
Revenue per $ Common Equity  0.00 
Revenue per $ Capital Invested  0.35 
Selling, General & Adm/tive (SG&A) as % of Revenue  137.0 
SG&A Expense as % of Revenue  5YEAR AVRG.  0.0 
Research & Devlopment (R&D) as % of Revenue  144.1 
R&D Expense as % of Revenue  5YEAR AVRG.  144.1 

 

 